Development of a humanized anti-FABP4 monoclonal antibody for treatment of breast cancer
J. Hao, R. Jin, Y. Yi, X. Jiang, J. Yu, Z. Xu, N. J. Schnicker, M. S. Chimenti, S. L. Sugg, B. Li
This paper develops humanized anti-FABP4 monoclonal antibodies that inhibit breast cancer tumor growth and metastasis by targeting FABP4's role in lipid metabolism.
bioRxiv · May 12, 2024 · PreprintCancer Biology